|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/47 | (2006.01) |
| (11) | Number of the document | 2418217 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11003985.6 |
| Date of filing the European patent application | 2006-09-12 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-27 |
| (46) | Date of publication of the claims translation | 2016-04-11 |
| (30) | Number | Date | Country code |
| PCT/EP2005/0097 | 2005-09-12 | WO |
| (72) |
Bonny, Christophe, CH
|
| (73) |
Xigen Inflammation Ltd.,
Arch. Makariou III 195 Neocleous House, 3030 Limassol,
CY
|
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | Į ląsteles patenkantys peptidiniai JNK signalo perdavimo kelio inhibitoriai |
| Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| Payment date | Validity (years) | Amount | |
| 2019-02-01 | 13 | 433.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-09-12 |